ABOS
Price:
$2.22
Market Cap:
$133.38M
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.[Read more]
Industry
Biotechnology
IPO Date
2021-07-01
Stock Exchange
NASDAQ
Ticker
ABOS
According to Acumen Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 93.64M. This represents a change of -41.32% compared to the average of 159.56M of the last 4 quarters.
The mean historical Enterprise Value of Acumen Pharmaceuticals, Inc. over the last ten years is 390.55M. The current 93.64M Enterprise Value has changed 2.30% with respect to the historical average. Over the past ten years (40 quarters), ABOS's Enterprise Value was at its highest in in the June 2021 quarter at 708.09M. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.
Average
390.55M
Median
151.44M
Minimum
89.25M
Maximum
800.50M
Discovering the peaks and valleys of Acumen Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 66.11%
Maximum Annual Enterprise Value = 800.50M
Minimum Annual Increase = -80.16%
Minimum Annual Enterprise Value = 89.25M
Year | Enterprise Value | Change |
---|---|---|
2023 | 148.26M | 66.11% |
2022 | 89.25M | -41.06% |
2021 | 151.44M | -80.16% |
2020 | 763.27M | -4.65% |
The current Enterprise Value of Acumen Pharmaceuticals, Inc. (ABOS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
129.65M
5-year avg
390.55M
10-year avg
390.55M
Acumen Pharmaceuticals, Inc.’s Enterprise Value is less than Terns Pharmaceuticals, Inc. (458.36M), greater than X4 Pharmaceuticals, Inc. (40.79M), less than Day One Biopharmaceuticals, Inc. (1.01B), greater than HOOKIPA Pharma Inc. (87.25M), greater than Amylyx Pharmaceuticals, Inc. (89.50M), less than Inozyme Pharma, Inc. (343.89M), less than Mereo BioPharma Group plc (582.99M),
Company | Enterprise Value | Market cap |
---|---|---|
458.36M | $549.60M | |
40.79M | $109.78M | |
1.01B | $1.25B | |
87.25M | $159.50M | |
89.50M | $161.36M | |
343.89M | $312.42M | |
582.99M | $664.26M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acumen Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Acumen Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Acumen Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Acumen Pharmaceuticals, Inc. (ABOS)?
What is the 3-year average Enterprise Value for Acumen Pharmaceuticals, Inc. (ABOS)?
What is the 5-year average Enterprise Value for Acumen Pharmaceuticals, Inc. (ABOS)?
How does the current Enterprise Value for Acumen Pharmaceuticals, Inc. (ABOS) compare to its historical average?